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The healing of chronic wounds is often affected by the presence of devitalized tissue that allows heavy growth of bacteria and the development of biofilm. The wound bed preparation including the cleaning and debridement of the wound bed as well as control of the exudate and bacterial load are principles that apply to wound management, because only a clean wound can heal. Based on current literature the combination of polihexanide and the surfactant component betaine has been found as a good candidate to accelerate wound autolytic debridement. 
STUDY DESIGN

BWAT Score inflammatory signs
Statistically significant differences between T0 and T4 for the following outcomes were found by using Prontosan ® Solution (PP) compared to normal saline (NS):
· Total score BWAT (p=0.0248) · BWAT score for inflammatory items (p=0.03) SECONDARY OUTCOME Pain scores were similar in both study groups, average score : 3.0, with minimal or no changes during the follow up. No adverse events related to the study device.
CONCLUSION
The results of this RCT confirms the superiority of Prontosan ® Solution in efficacy as it promotes the wound bed preparation, supports the reduction of inflammatory signs and accelerates the healing of vascular leg ulcers as well as pressure ulcers. 
